Why did R&I shift Nidec’s outlook to Negative?

R&I cited governance uncertainty and earnings risk after a third-party committee detailed accounting irregularities. The Nidec investigation report also flagged possible impairments around ¥250 billion. If cash flow weakens or governance fixes lag, funding costs may rise and a downgrade becomes more likely, affecting bonds and borrowing terms in Japan.

What did the Nidec investigation report actually find?

It described widespread, multi-year irregularities, highlighted internal control gaps, and warned of potential additional impairments near ¥250 billion. The third-party committee urged stronger independent oversight, tighter internal audit, and clearer accountability for estimates. Management now needs to implement these steps and provide transparent timelines in financial disclosures and earnings calls.

How could this affect the share price and funding costs?

Shares may stay volatile as investors price in impairment risk and compliance costs. A Negative outlook can lift bond and CP spreads and tighten loan terms. If the Nidec investigation report leads to sizable write-downs, earnings could reset lower near term. Clear governance progress could help stabilize both equity and debt pricing.

What should investors in Japan watch next?

Watch March 11 results and management’s Q&A on impairment timing, cash flow, and board oversight. Track any third-party committee follow-up, external auditor commentary, and R&I’s next actions. Also monitor working capital, interest coverage near 9.9x, and whether dividend and capex plans adjust as remediation spending ramps.

Is the dividend at risk after the report?

Dividend capacity looks supported by current liquidity and free cash flow, with a roughly 1.65% yield and a 40 yen DPS. However, the Nidec investigation report raises uncertainty. Large impairments or weaker cash flow could prompt a review. Management’s stance on payout will likely be updated with earnings guidance.

Global Market Insights

6594.T Stock Today: R&I Revises Outlook to Negative – March 05

ByHuzaifa Zahoor March 5, 2026March 5, 2026

Nidec investigation report is front and center after Japan’s R&I revised the company’s outlook to Negative on March 5. The decision follows a third-party committee’s findings of years of accounting irregularities and possible additional impairments of about ¥250 billion. Shares of 6594.T last traded near ¥2,320, up 2.38%, with volume almost double the average. We break down what the R&I negative outlook means for funding costs, how governance risk could hit earnings, and the key dates investors in Japan should watch.